Erweiterte Suche

Herr Eilard Friese ist Vorstandsvorsitzender & Chief Executive Officer bei Aegon NV, stellvertretender Vorsitzender bei ING Verzekeringen NV und Mitglied bei The Geneva Association. Er ist Mitglied des Board of Directors der Vereniging Aegon NV. Herr Friese war zuvor als Vorstandsvorsitzender & CEO bei NN Group NV, als stellvertretender Vorsitzender bei NN Insurance Eurasia NV, als Chief Executive Officer bei ING Insurance Benelux, als Chief Executive Officer bei Nationale Nederlanden NV, als stellvertretender Vorsitzender & Chief Executive Officer bei Cesk pojitovna as, als SVP & Chief Retailer Services Officer-Europe bei A.C. Nielsen Co. & Co. SA, ein Senior Vice President bei AEGON Sony Life Insurance Co., Ltd, ein Principal bei Vivat NV und ein Mitglied des Aufsichtsrates bei NN Group Bidco BV. Außerdem war er Vorstandsmitglied bei AEGON Levensverzekering NV. Er erhielt seinen Hochschulabschluss an der Universität Utrecht.

Joachim Friese was associated with FRIESE GmbH, where he held the position of Managing Director in 2012.
He founded FRIESE GmbH in 1992.

Karen Friese has worked as a Director at The Austin Chamber of Commerce since 2011.

Karen A.
Friese is the founder of K Friese & Associates, Inc., where she currently holds the title of President & Chief Executive Officer.
She founded the company in 2003.
Ms. Friese is also currently employed as a Director at H.W.
Lochner, Inc., where she started in 2023.

Gregory Friese currently works as a Director at Camp Manito-Wish Y.M.C.A., Inc.

Jeremy L.
Friese was the founder of Evidentia Health, Inc. (2012) and Verata Health, Inc. (2017), where he held the title of Chief Executive Officer until 2020.
He is also the founder of Medcon Partners, LLC.
Dr. Friese's current jobs include Director at OneOme LLC, Director at Mysimplepetlab, Inc., Independent Director at First Digital Health Acquisition Corp., and Advisor at Invenshure LLC.
Dr. Friese's former jobs include Director at RAYUS Radiology (2018-2020), Senior Medical Director-Business Development at The Mayo Clinic (Old) (2012-2014), Director at American Cancer Society, Inc., Director at International Monetary Fund, Director at Lifecode, Inc. (2012-2015), Director at Ostra Cybersecurity, Inc. (2018-2020), Board Member at Harvard Management Co., Inc. (2017-2019), Board member at International Monetary Fund (2016-2018), Advisor at Medtronic AB (2016-2020), and President-Payer Market at Olive AI, Inc. (2020-2022).
Dr. Friese's education includes an MBA from Harvard Business School (2008) and a doctorate from Mayo Clinic College of Medicine & Science.

Chad Friese has worked as a Director at Ring-neck Energy & Feed LLC and Renewable Fuels Association.

Christopher Friese has a career history that includes a current job as a Member-Governors Board at the Patient-Centered Outcomes Research Institute.

Mathias Friese worked as a Risk Manager & Analyst at Shareholder Value Management AG.

Johann Friese is currently a Principal at The Sterling Group LP.
Prior to this, he worked as a Private Equity Associate at Advent International LP from 2014 to 2016, and as an Analyst at JPMorgan Chase & Co. from 2011 to 2014.
Mr. Friese completed his undergraduate degree at the University of Mannheim in 2010 and obtained an MBA from Harvard Business School in 2018.

Stefan Friese currently works at Neuecapital Partners, as Managing Partner.
Mr. Friese also formerly worked at Snom Technology GmbH, as Chairman-Supervisory Board and Beaufort Capital GmbH, as Partner from 2002 to 2014.
Mr. Friese received his graduate degree from Technical University of Berlin.

Jonathan Friese currently works as a Director at Bridging, Inc.

Jenny Friese held several positions in different firms.
She worked as a Managing Director at Deutsche Apotheker- & Ärztebank EG (Private Banking) from 2021 to 2022.
She also worked as a Member-Management Board at DEUTSCHE APOTHEKER-.
UND ÄRZTEBANK eG from 2021 to 2022.
Additionally, she served as a Member-Supervisory Board at Commerz Real AG.